Cingulate Inc. Accrued Bonuses, Current
Cingulate Inc. (CING) had Accrued Bonuses, Current of $175.63 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Employee-related Liabilities, Current
us-gaap:AccruedBonusesCurrent · last filed 2023-11-13
- 2023-09-30: Accrued Bonuses, Current $175.63K.
- 2023-06-30: Accrued Bonuses, Current $175.63K.
- 2023-03-31: Accrued Bonuses, Current $175.63K.
- 2022-12-31: Accrued Bonuses, Current $175.63K.
| Period end | Accrued Bonuses, Current |
|---|---|
| 2023-09-30 | $175.63K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $175.63K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $175.63K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $175.63K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |